K - that's a fascinating read, and I personally have quite a lot of belief that the mind can control our physical wellbeing. To a point. I don't trust the entirety of the "confounding" placebo result in the IMAGINE trial, mainly because of my understanding that there has never been a placebo result showing benefit (not just reduced decline) over such a long period for AD.
My alternative theories on the IMAGINE placebo result are:
1. The imaging method gives results that bounce around, and the placebo cohort was too small to average this out
2. A few of the placebo patients weren't suffering AD, rather they were suffering a more temporary affliction which was improved by time, placebo effect, or both
3. A few sneaky placebo patients found out where the "good stuff" was stored (actually I think this is incredibly unlikely, but a mix up of PBT2 & placebo for a small handful of patients is a close cousin that I do think possible)
So regardless of the reason, I have thought that Prana should consider selling the placebo (not the drug, the experience!). I'm sure some people would be lining up. The NY Times article would help to sell the idea...
- Forums
- ASX - By Stock
- ATH
- I don't know! Maybe...
ATH
alterity therapeutics limited
Add to My Watchlist
11.1%
!
1.0¢

I don't know! Maybe..., page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $91.27M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 0.9¢ | $9.419K | 1.001M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 63876237 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 4097409 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
37 | 63876237 | 0.009 |
20 | 10741186 | 0.008 |
18 | 11127963 | 0.007 |
12 | 7003518 | 0.006 |
6 | 3460001 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 4097409 | 8 |
0.011 | 8119746 | 22 |
0.012 | 13507542 | 22 |
0.013 | 6265068 | 10 |
0.014 | 12788180 | 6 |
Last trade - 16.15pm 04/07/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online